. Genome stability is critically important for human health. This is apparent from the myriad of inherited human syndromes characterized by defective DNA damage responses. The nervous system is particularly prone to the consequences of genome damage, which can lead to neurodegeneration or neurodevelopmental disorders. Defects in genome maintenance are also increasingly being linked to broader neurologic health issues, including age-related neurodegenerative events that mar cognitive ability and quality of life. Therefore, understanding the mechanistic connections between faulty DNA damage signaling and human disease is of fundamental biomedical importance. The neurodegenerative syndrome ataxia telangiectasia (A-T), which results from loss of function of the DNA damage-signaling serine/threonine kinase ATM (ataxia telangiectasia, mutated), exemplifies the importance of genome stability in the nervous system. However, despite intense interest in the molecular details of ATM function, its role in the nervous system remains elusive, as little is known about the genomic lesions or key substrates that activate ATM in an in vivo neural setting. We recently showed that ATM is critical for preventing the accumulation of Topoisomerase-1-DNA cleavage complexes (Top1cc) in the nervous system, which can lead to DNA strand breaks. This pathogenic Topoisomerase-1-DNA lesion directly impacts genome stability and may underpin disease etiology in A-T and other related neurodegenerative syndromes. Our studies have also revealed that elevation of DNA damage associated with ATM loss results in transcriptional disruption of essential cerebellar genes via the occurrence of pathogenic R-loops, a DNA/RNA intermediate that can form during transcription. These data have lead to our hypothesis that aberrant topoisomerase activity and causally related R-loops are etiologic genotoxins contributing to neurodegeneration in A-T and related disorders. Many genome stability factors (including ATM) that regulate topoisomerase function or restrain R-loop formation are linked to neurologic disease, suggesting a critical regulatory genome maintenance axis that prevents these potentially damaging lesions from causing neurodegeneration. During the prior grant cycle we developed multiple unique mouse models with which to interrogate ATM function, and to determine the pathogenic impact of specific genome lesions in the nervous system. These unique mouse models are central to the experiments proposed in this application. Amongst these is an inducible Topoisomerase-1 mutation that promotes formation of Top1cc in the nervous system, which synergizes strongly with ATM loss to cause cerebellar dysfunction and ataxia. This proposal will provide substantial new information to enhance our understanding of the central mechanisms that maintain the neural genome. Moreover, data from this work will provide important groundwork for the eventual development of therapeutic approaches to treat neurological disease resulting from genome instability.

Public Health Relevance

statement A multitude of human syndromes are caused by mutation of factors needed to maintain genome integrity. These syndromes are characterized by profound neurological defects including neurodegeneration or brain tumors. These diseases illustrate the importance of DNA repair for brain development and continuing health. Understanding how DNA repair pathways function during both nervous system development and in the mature brain is critical for the development of treatments for these and other diseases. This grant application proposes a number of new approaches to investigate how specific DNA repair pathways prevent brain disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS037956-21
Application #
9851944
Study Section
Neural Oxidative Metabolism and Death Study Section (NOMD)
Program Officer
Zhang, Ran
Project Start
1998-08-01
Project End
2023-01-31
Budget Start
2020-02-01
Budget End
2021-01-31
Support Year
21
Fiscal Year
2020
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
ElInati, Elias; Russell, Helen R; Ojarikre, Obah A et al. (2017) DNA damage response protein TOPBP1 regulates X chromosome silencing in the mammalian germ line. Proc Natl Acad Sci U S A 114:12536-12541
Hoch, Nicolas C; Hanzlikova, Hana; Rulten, Stuart L et al. (2017) XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia. Nature 541:87-91
Dumitrache, Lavinia C; McKinnon, Peter J (2017) Polynucleotide kinase-phosphatase (PNKP) mutations and neurologic disease. Mech Ageing Dev 161:121-129
McKinnon, Peter J (2017) Genome integrity and disease prevention in the nervous system. Genes Dev 31:1180-1194
Illuzzi, Jennifer L; McNeill, Daniel R; Bastian, Paul et al. (2017) Tumor-associated APE1 variant exhibits reduced complementation efficiency but does not promote cancer cell phenotypes. Environ Mol Mutagen 58:84-98
Chiang, Shih-Chieh; Meagher, Martin; Kassouf, Nick et al. (2017) Mitochondrial protein-linked DNA breaks perturb mitochondrial gene transcription and trigger free radical-induced DNA damage. Sci Adv 3:e1602506
Enriquez-Rios, Vanessa; Dumitrache, Lavinia C; Downing, Susanna M et al. (2017) DNA-PKcs, ATM, and ATR Interplay Maintains Genome Integrity during Neurogenesis. J Neurosci 37:893-905
Higo, Tomoaki; Naito, Atsuhiko T; Sumida, Tomokazu et al. (2017) DNA single-strand break-induced DNA damage response causes heart failure. Nat Commun 8:15104
Canela, Andres; Maman, Yaakov; Jung, Seolkyoung et al. (2017) Genome Organization Drives Chromosome Fragility. Cell 170:507-521.e18
Zhan, Hong; Aizawa, Kenichi; Sun, Junqing et al. (2016) Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity. Cardiovasc Res 110:85-95

Showing the most recent 10 out of 70 publications